GLP-1 Industries Transitioning to Oral Medications
The GLP-1 weight-loss and diabetes industries are continuing a strategic shift towards oral medication development, according to Lexaria Bioscience Corp. Lexaria's DehydraTECH™ technology is currently under evaluation by the company for this transition.